N

Nitrome Biosciences, Inc.

18 employees

Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2018

Funding rounds raised

Total raised

$38M

from 7 investors over 7 rounds

N

Nitrome Biosciences, Inc. raised $7M on November 2, 2021

Investors: Mission Bay Capital, Bristol-Myers Squibb, UK, The Dementia Discovery Fund and Sofinnova Partners

N

Nitrome Biosciences, Inc. raised $38M on April 22, 2020

Investors: Mission Bay Capital, Sofinnova Partners and The Dementia Discovery Fund

FAQ